E126: Can We Slow Aging? How Science Is Extending Healthspan - w/ Prof Richard Faragher

In this episode, Jesse speaks with Professor Richard Faragher, one of the UK’s leading researchers on the biology of aging. They dive deep into why only 18% of people age well, what it means to age badly, and how emerging science is changing our understanding of aging itself.Topics include:The biological and economic toll of agingEvidence that aging is “druggable”Promising research on rapamycin, metformin, and senolyticsWhy repurposed drugs could extend healthy lifespan todayChallenges with clinical trials and drug development costsSocial and economic divides in access to anti-aging therapiesThe role of loneliness, purpose, and lifestyle in agingHow aging compares to other diseases in public perception and fundingThe potential for aging interventions to delay multiple diseases at onceWhat individuals can do now to age betterFaragher also reflects on the political and commercial future of anti-aging medicine—and the race to control its patents.Guest Bio: Dr. Richard Faragher is a professor of biogerontology at the University of Brighton. His research focuses on cellular senescence and the mechanisms of aging, and he’s a leading advocate for translating aging science into real-world interventions.📺Watch the full pod on YouTube 📺https://youtu.be/x6Nru2NkFEM 🎙 The Pod is hosted by Jesse Wright💬 For guest suggestions, questions, or media inquiries, reach out at https://elpodcast.media/📬 Never miss an episode – subscribe and follow wherever you get your podcasts.⭐️ If you enjoyed this episode, please rate and review the show. It helps others find us. Thanks for listening!